Asian Pacific Journal of Cancer Prevention

  • 제13권12호
  • /
  • Pages.6133-6137
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Neck Node Bolus Technique in the Treatment of Nasopharyngeal Carcinoma with Intensity-modulated Radiotherapy

  • Phua, Chee Ee (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Ung, Ngie Min (Clinical Oncology Unit, Faculty of Medicine, University of Malaya) ;
  • Tan, Boon Seang (Department of Clinical Oncology and Radiotherapy) ;
  • Tan, Ai Lian (Department of Clinical Oncology and Radiotherapy) ;
  • Eng, Kae Yann (Department of Clinical Oncology and Radiotherapy) ;
  • Ng, Bong Seng (Department of Clinical Oncology and Radiotherapy)
  • 발행 : 2012.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: To study the effect of bolus versus no bolus in the coverage of the nodal tumour volume with intensity-modulated radiotherapy (IMRT) for the treatment of nasopharyngeal carcinoma (NPC). Methods and Materials: This retrospective study used data from 5 consecutive patients with NPC who were treated with bolus for large neck nodes using IMRT from November 2011-January 2012 in our institute. All these patients were treated radically with IMRT according to our institution's protocol. Re-planning with IMRT without bolus for these patients with exactly the same target volumes were done for comparison. Comparison of the plans was done by comparing the V70 of PTV70-N, V66.5 of PTV70-N, V65.1 of PTV70-N and the surface dose of the PTV70-N. Results: The mean size of the largest diameter of the enlarged lymph nodes for the 5 patients was 3.9 cm. The mean distance of the GTV-N to the skin surface was 0.6 cm. The mean V70 of PTV70-N for the 5 patients showed an absolute advantage of 10.8% (92.4% vs. 81.6%) for the plan with bolus while the V66.5 of PTV70-N had an advantage of 8.1% (97.0% vs. 88.9%). The mean V65.1 also had an advantage of 7.1% (97.6% vs. 90.5%). The mean surface dose for the PTV70-N was also much higher at 61.1 Gy for the plans with bolus compared to only 23.5 Gy for the plans without bolus. Conclusion: Neck node bolus technique should be strongly considered in the treatment of NPC with enlarged lymph nodes treated with IMRT. It yields a superior dosimetry compared t o non-bolus plans with acceptable skin toxicity.

키워드

참고문헌

  1. Annyas AA, Snow GB, van Slooten EA, Bartelink GMM, Hart A (1979). Prognostic factors of neck node metastasis: Their impact on planning a treatment regimen. American Society of Head and Neck Surgeons. Los Angeles.
  2. Apisarnthanarax S, Elliott DD, El-Naggar AK, et al (2006). Determining optimal clinical target volume margins in head and neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys, 64, 678-83. https://doi.org/10.1016/j.ijrobp.2005.08.020
  3. Baujat B, Bourhis J, Chan AT, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phy, 64, 47-56 https://doi.org/10.1016/j.ijrobp.2005.06.037
  4. Carter RL, Bliss JM, Soo KC, O'Brien CJ (1987). Radical neck dissections for squamous cell carcinomas: Pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys, 13, 825-32. https://doi.org/10.1016/0360-3016(87)90094-0
  5. Chao KS, Ozyigit G, Blanco AI, et al (2004). Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumour volume. Int J Radiat Oncol Biol Phys, 59, 43-50. https://doi.org/10.1016/j.ijrobp.2003.08.004
  6. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF (2002). Determination and delineation of nodal target volumes for head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys, 53, 1174-84. https://doi.org/10.1016/S0360-3016(02)02881-X
  7. Cheng JC, Chao KS, Low D (2001). Comparison of intensity-modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer, 96, 126-31. https://doi.org/10.1002/ijc.1004
  8. Chong VFH, Fan YF (1997). Pterygopalatine fossa and maxillary nerve infiltration in nasopharyngeal carcinoma. Head Neck, 19, 121-5. https://doi.org/10.1002/(SICI)1097-0347(199703)19:2<121::AID-HED6>3.0.CO;2-6
  9. Emami B, Lyman J, Brown A, et al (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21, 109-22.
  10. Fowler JF, Lindstrom MJ (1992). Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys, 23, 457-67. https://doi.org/10.1016/0360-3016(92)90768-D
  11. Glastonbury C (2007). Nasopharyngeal carcinoma. The role of magnetic resonance imaging in diagnosis, staging, treatment and follow-up. Top Magn Reson Imaging, 18, 225-35. https://doi.org/10.1097/RMR.0b013e3181572b3a
  12. Hirabayashi H, Koshii K, Uno K, et al (1991). Extracapsular spread of squamous cell carcinoma in neck lymph nodes: Prognostic factor of laryngeal cancer. Laryngoscope, 101, 502-6.
  13. Hunt MA, Zelefsky M, Wolden S, et al (2001). Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys, 49, 623-32. https://doi.org/10.1016/S0360-3016(00)01389-4
  14. ICRU Report 50 (1993). Prescribing, recording and reporting photon beam therapy. Bethesda, MD, International Commision on Radiation Units and Measurements.
  15. ICRU Report 62 (1999). Prescribing, recording and reporting photon beam therapy (supplement to ICRU 50). Bethesda, MD, International Commision on Radiation Units and Measurements.
  16. Johnson JT, Barnes EL, Myers EN, et al (1981). The extracapsular spread of tumours in cervical node metastasis. Arch Otolaryngol, 107, 725-29. https://doi.org/10.1001/archotol.1981.00790480001001
  17. Kam KM, Chau MC, Suen J, Choi PHK, Teo PML (2003). Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility in dose escalation. Int J Radiat Oncol Biol Phys, 56, 145-57. https://doi.org/10.1016/S0360-3016(03)00075-0
  18. King AD, Ahuja AT, Leung SF, et al (2000). Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck, 22, 275-81. https://doi.org/10.1002/(SICI)1097-0347(200005)22:3<275::AID-HED10>3.0.CO;2-N
  19. Kristensen CA, Kjaer-Kristoffersen F, Sapru W, et al (2007). Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncologica, 46, 214-20. https://doi.org/10.1080/02841860600635862
  20. Kwong DL, Pow EH, Sham JS, et al (2004). Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer, 101, 1584-93. https://doi.org/10.1002/cncr.20552
  21. Kwong DL, Sham JS, Leung LH, et al (2006). Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 64, 374-81. https://doi.org/10.1016/j.ijrobp.2005.07.968
  22. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol, 22, 4604-12. https://doi.org/10.1200/JCO.2004.10.074
  23. Lee N, Xia P, Quivey JM, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22. https://doi.org/10.1016/S0360-3016(02)02724-4
  24. Lee SW, Back GM, Yi BY et al (2006). Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 65, 152-60. https://doi.org/10.1016/j.ijrobp.2005.10.040
  25. Maciejewski B, Preuus-Bayer G, Trott KR (1983). The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys, 9, 321-8. https://doi.org/10.1016/0360-3016(83)90290-0
  26. Maciejewski B, Withers HR, Taylor JM, Hliniak A (1989). Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys, 16, 831-43. https://doi.org/10.1016/0360-3016(89)90503-8
  27. Mao YP, Liang SB, Liu LZ, et al (2008). The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res, 14, 7497-503. https://doi.org/10.1158/1078-0432.CCR-08-0271
  28. Ng SH, Chan SC, Yen TC et al (2004). Nodal metastases of nasopharyngeal carcinoma:patterns of disease on MRI and FDG PET. Eur J Neck Med Mol Imaging, 31, 1073-80.
  29. Phua CE, Tan BS, Yong TK, Govindasamy M (2011). Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Penang General Hospital from 2001-2005. Asian Pac J Cancer Prev, 12, 3197-200.
  30. Pow EH, Kwong DL, Mcmillan AS, et al (2006). Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys, 66, 981-91. https://doi.org/10.1016/j.ijrobp.2006.06.013
  31. Price S, Williams M, Butson M, Metcalfe P (2006). Comparison of skin dose between conventional radiotherapy and IMRT. Australas Phys Emg Sci Med, 29, 272-7. https://doi.org/10.1007/BF03178577
  32. Sham JST, Choy D, Wei WI (1990). Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys, 19, 929-33. https://doi.org/10.1016/0360-3016(90)90014-B
  33. Studer G, Brown M, Salgueiro EB, et al (2011). Grade $\frac{3}{4}$ dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys, 81, 110-7. https://doi.org/10.1016/j.ijrobp.2010.05.018
  34. Sultanem K, Shu HK, Xia P, et al (2000). Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys, 48, 711-22. https://doi.org/10.1016/S0360-3016(00)00702-1
  35. Vikram B, Mishra UB, Strong EW, Manolatos S (1985). Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys, 11, 1455-9. https://doi.org/10.1016/0360-3016(85)90332-3
  36. Wu S, Xie Cy, Jin X, Zhang P (2006). Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer: a local center's experience. Int J Radiat Oncol Biol Phys, 66, 540-6.
  37. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ (2000). Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 48, 329-37.